Synthesis of P-Stereogenic Diarylphosphinamides as Novel Inhibitors of Melanoma
Tóm tắt
In this paper, the evaluation on the biological activity of an array of P-stereogenic diaryphosphinamides as novel inhibitors of malignant melanoma was presented. Among 20 derivatives being screened, several of them displayed high inhibition rate up to 90% against the B16 melanoma cells at 100 μg/mL. Moreover, one of them displayed high inhibition activity with IC50 value of 5.8 μg/mL. In contrast, a comparative assay showed that all the compounds were almost inactive or showed only very weak inhibition ability against an array of cell lines including HL7702, Bel7402, HT1080, A549 and McF7 cells. The results suggested that the P-stereogenic diarylphosphinamides may serve as a class of novel lead molecules for further development of new inhibitors for selective inhibition of melanoma.
Tài liệu tham khảo
Gladfelter P., Darwish N. H. E., Mousa S. A., Melanoma Res., 2017, 27(5), 403
Siegel R. L., Miller K. D., Jemal A., CA Cancer J. Clin., 2016, 66(1), 7
Tronnier M., Mitteldorf C., Cancer Manag. Res., 2014, 6, 349
McArthur G. A., Chapman P. B., Robert C., Larkin J., Haanen J. B., Dummer R., Ribas A., Hogg D., Hamid O., Ascierto P. A., Lancet Oncol., 2014, 15(3), 323
Trinh V. A., Davis J. E., Anderson J. E., Kim K. B., Ann. Pharmacother., 2014, 48(4), 519
Lugowska I., Kosela-Paterczyk H., Kozak K., Rutkowski P., Onco. Targets Ther., 2015, 8, 2251
Shahabi V., Whitney G., Hamid O., Schmidt H., Chasalow S. D., Alaparthy S., Jackson J. R., Cancer Immunol. Immuother., 2012, 61(5), 733
Ugurel S., Röhmel J., Ascierto P. A., Flaherty K. T., Grob J. J., Hauschild A., Larkin J., Long G. V., Lorigan P., McArthur G. A., Ribas A., Robert C., Schadendorf D., Garbe C., Eur. J. Cancer, 2016, 53, 125
van Leeuwen P. W. N. M., Kamer P. C. J., Claver C., Pàmies O., Diéguez M., Chem. Rev., 2011, 111(3), 2077
Wang D., Chen Q., Lu S., Zhou Y., Chem. Rev., 2012, 112(4), 2557
Xie J. H., Zhu S. F., Zhou Q. L., Chem. Soc. Rev., 2012, 41(11), 4126
Chen Q., Ye Z., Duan Y., Zhou Y., Chem. Soc. Rev., 2013, 42(2), 497
Dutartre M., Bayardon J., Juge S., Chem. Soc. Rev., 2016, 45(20), 5771
Yang H., Yang X., Tang W., Tetrahedron, 2016, 72(41), 6143
You S., Cai Q., Zeng M. Chem. Soc. Rev., 2009, 38(8), 2190
Wei Y., Shi M., Acc. Chem. Res., 2010, 43(7), 1005
Mahlau M., List B., Angew. Chem. Int. Ed., 2013, 52(2), 518
Brak K., Jacobsen E. N., Angew. Chem. Int. Ed., 2013, 52(2), 534
Phipps R. J., Hamilton G. L., Toste F. D., Nat. Chem., 2012, 4(8), 603
Remond E., Juge S., Chim. Oggi., 2014, 32(4), 49
Parmar D., Sugiono E., Raja S., Rueping M., Chem. Rev., 2014, 114(18), 9047
Dang Q., Liu Y., Cashion D. K., Kasibhatla S. R., Jiang T., Taplin F., Jacintho J. D., Li H., Sun Z., Fan Y., DaRe J., Tian F., Li W., Gibson T., Lemus R., van Poelje P. D., Potter S. C., Erion M. D., J. Med. Chem., 2011, 54(1), 153
Lassaux P., Hamel M., Gulea M., Delbrück H., Mercuri P. S., Horsfall L., Dehareng D., Kupper M., Frère J. M., Hoffmann K., Galleni M., Bebrone C., J. Med. Chem., 2010, 53(13), 4862
Zhao Y. L., Wu G. J., Han F. S., Chem. Commun., 2012, 48(47), 5868
Zhao Y. L., Wu G. J., Li Y., Gao L. X., Han F. S., Chem. Eur. J., 2012, 18(31), 9622
Guan J., Wu G. J., Han F. S., Chem. Eur. J., 2014, 20(12), 3301
Du Z. J., Guan J., Wu G. J., Xu P., Gao L. X., Han F. S., J. Am. Chem. Soc., 2015, 137(2), 632
Chen Y. H., Qin X. L., Guan J., Du Z. J., Han F. S., Tetrahedron: Asymmetry, 2017, 28(4), 522
Chen Y. H., Qin X. L., Han F. S., Chem. Commun., 2017, 53(43), 5826
Müller K., Faeh C., Diederich F., Science, 2007, 317(5846), 1881
Sheldrick G. M., Acta Crystallogr A, 2008, 64, 112
Sheldrick G. M., Acta Crystallogr A, 2015, 71, 3
Sheldrick G. M., Acta Crystallogr C, 2015, 71, 3
Carpino L. A., Xia J., Zhang, C., El-Faham A., J. Org. Chem., 2004, 69(1), 62
McPake C. B., Murray C. B., Sandford G., Aust. J. Chem., 2013, 66(2), 145
Yan X., Tang X. X., Chen L., Yi Z. W., Fang M. J., Wu Z., Qiu Y. K., Mar. Drugs, 2014, 12(4), 2156